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Abstract
Aims: To determine whether there are gender-based differences in in-hospital outcomes among patients 
undergoing percutaneous coronary intervention (PCI).
Methods and results: We studied a large cohort using clinical data from a registry of 130,985 PCI pro-
cedures in Belgium, from January 2006 to February 2011. Compared to males, females were significantly 
older (70.3 vs. 64.8 years), and were more frequently diabetic or hypertensive. Men smoked more and more 
frequently had previous myocardial infarction (MI), previous PCI or previous coronary artery bypass graft 
(CABG) surgery. Coronary artery disease (CAD) was less severe in women, and PCI to the left anterior 
descending artery was more common in female patients. Unadjusted in-hospital mortality rates were higher 
in females versus males (2.5% for women and 1.6% for men, p<0.0001). After multivariable analysis, female 
gender remained an independent predictor of mortality (odds ratio 1.35, 95% CI: 1.22-1.49, p<0.0001).
Conclusions: Gender-based differences in hospital mortality rates after PCI were observed in this large reg-
istry. Female sex remained an independent predictor of mortality after multivariable adjustment.
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Despite significant advances in the management of coronary artery 
disease (CAD), this pathology is still one of the major causes of 
death worldwide today1. Cardiovascular disease is the first cause 
of death in women in Europe. According to the European Heart 
Network, cardiovascular disease accounts for 42% of deaths in 
women under 75 years of age2. Even though the prevalence of 
CAD is greater in men than in women at any given age, several 
reports have shown that female gender is associated with worse out-
comes in case of ischaemic heart disease3,4. Gender-related differ-
ences in the pathophysiology of atherosclerosis5, in cardiovascular 
risk factors6, in clinical presentation7 and in the diagnosis of coro-
nary artery disease8 are well known. Recently, analyses from the 
PROSPECT study showed that there were gender-specific differ-
ences in the extent and composition of coronary plaques in patients 
<65 years of age, suggesting that atherosclerosis development and 
progression were influenced by gender9,10. Differences according to 
sex have also been outlined in the management and outcomes after 
acute coronary syndromes11. Concerning outcomes after percutane-
ous coronary intervention (PCI), the question is still debated and 
controversial. In earlier studies, female gender was identified as an 
independent predictor of adverse outcome after PCI12. In contrast, 
more recent studies have demonstrated that female gender had no 
or minimal impact on outcomes after adjustment for clinical and 
anatomical variables13,14.
The aim of this study was to analyse gender differences in in-
hospital outcomes in patients who underwent PCI in Belgium from 
January 2006 to February 2011.
Methods
PATIENT POPULATION
The Belgian Working Group on Interventional Cardiology registry 
is a prospective procedure-based database. A web-based standard-
ised case record form (CARDS database, European Heart House, 
Nice, France) is completed for each procedure, allowing collection 
of detailed data in all patients undergoing PCI in the 36 Belgian 
hospitals performing PCI. Data collection includes clinical, demo-
graphic, procedural and angiographic characteristics as well as in-
hospital outcomes.
We analysed data from January 2006 to February 2011. During 
this period, 131,119 procedures were performed. Of these, 134 pro-
cedures were excluded from the analysis due to missing gender data.
ENDPOINTS AND STUDY DEFINITIONS
The primary outcome for this study was all-cause in-hospital mor-
tality. Secondary endpoints included the need for coronary artery 
bypass grafting, cerebrovascular accident (CVA), major bleed-
ing, major vascular complication, renal failure requiring dialysis, 
post-procedural myocardial infarction and acute stent thrombo-
sis. A composite secondary endpoint only including major adverse 
cardiac and cerebrovascular events (MACCE) was also analysed. 
Standard definitions were used to define the most common clini-
cal scenarios.
STATISTICAL ANALYSIS
Categorical variables are presented as counts and percentages. 
Continuous variables are presented as mean±SD. Differences 
were deemed significant if p<0.05. We used the chi-square test 
and Student’s t-test to compare groups, as appropriate. Regression 
analysis was performed using univariable then multivariable logis-
tic regression modelling in order to identify the independent pre-
dictors of death and secondary endpoints. Multivariable models 
were formed by including significant univariable predictors for the 
outcome variable of interest. Variables with a value of p<0.10 in 
univariate analysis were incorporated into the model in a forward 
stepwise manner. All statistical analyses were performed with SPSS 
version 17 (SPSS Inc., Chicago, IL, USA).
Results
BASELINE, ANGIOGRAPHIC AND INTERVENTION 
CHARACTERISTICS
Among the 130,985 PCI performed, 35,955 were performed in 
women. Compared with men, women were significantly older and 
were more likely to have diabetes, hypertension, chronic renal 
failure (CRF), prior stroke, previous valvular heart disease (VHD) 
or previous congestive heart failure. Conversely, history of prior 
MI, prior PCI, prior CABG surgery or prior peripheral vascular 
disease (PVD) were less frequent in women than in men. Women 
were also less likely to be smokers. Of note, the proportion of 
patients with hypercholesterolaemia was similar in both groups 
(Table 1).
Regarding PCI indication, most cases were elective procedures in 
both groups but men were more likely to present with ST-segment 
elevation myocardial infarction (STEMI). Cardiogenic shock and 
inotropic support at presentation were more frequent in women. 
Reduced left ventricle function was more common in male patients. 
A significant gender-based difference was observed in the sever-
ity of CAD, with more frequent single-vessel disease in women 
and more high-risk coronary artery disease (defined as left main 
artery stenosis, 3-vessel disease, 2-vessel disease with proximal left 
anterior descending artery disease) in men. The lesions more often 
involved the left anterior descending coronary artery in women and 
more frequently the left circumflex artery and grafts in men. The 
procedural data showed a slightly greater number of treated vessels 
and treated lesions per patient in men (Table 2).
CLINICAL OUTCOMES
In-hospital death rate was 1.8% (n=2,297), and women had 
a significantly higher risk of death: 2.5% vs. 1.6% in men 
(p<0.0001), odds ratio (OR) 1.57, 95% confidence interval (CI): 
1.44-1.70, p<0.0001 (Table 3, Figure 1). Women had a higher risk 
of in-hospital death after PCI in all clinical settings (i.e., acute 
coronary syndrome [ACS] and stable angina), but the difference 
in death rate was particularly high in case of acute coronary syn-
drome, especially in case of STEMI. There was a graded rela-
tionship between mortality rates and clinical indication for PCI: 
elective PCI (0.7% vs. 0.5%, p=0.003), to NSTE-ACS (2.4% vs. 
























for females vs. 
males
Baseline clinical characteristics
Age, years 66.3±11.8 64.8±11.6 70.3±11.3 <0.0001
Height, cm 169.8±8.7 173.2±6.9 160.9±6.5 <0.0001
Weight, kg 79.3±15.1 82.6±14.2 70.8±13.9 <0.0001
BMI, kg/m² 27.4±4.5 27.5±4.3 27.4±5.2 0.008
Obesity, % 24.2 23.4 26.3 <0.0001
BSA, m² 1.93±0.21 1.99±0.19 1.77±0.19 <0.0001
Previous angina, % 4.9 4.8 5.2 0.002
Previous MI, % 16.3 17.9 12.3 <0.0001
CRF, % 3.3 3.1 3.6 <0.0001
Previous CHF, % 2.1 2.1 2.4 0.001
Previous PCI, % 28.6 29.9 25.4 <0.0001
Previous CVA, % 3.1 3.0 3.4 <0.0001
Previous CABG surgery, % 9.9 10.8 7.4 <0.0001
Previous PVD, % 7.6 7.9 6.8 <0.0001
Previous VHD, % 2.1 1.8 2.9 <0.0001
Current smoking, % 27.8 30.8 19.8 <0.0001
Former smoking, % 31.0 36.8 15.4 <0.0001
Diabetes, % 22.1 20.3 26.8 <0.0001
Insulin-dependent diabetes, % 5.0 4.2 7.4
<0.0001
Non-insulin-dependent diabetes, % 17.1 16.1 19.4
Hypertension, % 55.8 52.9 63.3 <0.0001
Hypercholesterolaemia, % 58.6 58.4 58.9 0.112
Initial evaluation
Pre-procedural elevated biomarkers, % 24.4 24.2 24.8 0.226
Pre-procedural thrombolysis (STEMI), % 3.7 3.9 3.1 0.002
Cardiogenic shock, % 1.9 1.9 2.1 0.001
Pre-procedural cardiopulmonary reanimation, % 1.5 1.6 1.5 0.748
Haemodynamic support, % 1.1 1.1 1.3 0.003
LV ejection fraction, % >50 % 78.1 77.1 80.5 <0.0001
≤50% 21.9 22.9 19.5
<0.0001
41-50% 12.1 12.7 10.4
31-40% 6.0 6.2 5.6
<= 30% 3.8 3.9 3.4
Clinical indications for PCI, %
STEMI 16.6 17.3 14.9
<0.0001
NSTE-ACS 13.6 13.5 14.0
Stabilised ACS 19.0 18.7 19.6
Elective indications, others 50.8 50.5 51.5
Lesion characteristics
Number of diseased 
vessels, %
1 47.1 45.4 51.5
<0.00012 31.0 31.4 29.8
3 21.9 23.1 18.7
Coronary anatomic risk *, % High 24.3 25.4 21.2
<0.0001
Low 75.7 74.6 78.8
* High anatomic risk: left main artery stenosis, 3-vessel disease, 2-vessel disease with proximal left anterior descending artery disease; low anatomic 
risk: other 2-vessel disease, 1-vessel disease. ACS: acute coronary syndrome; BMI: body mass index; BSA: body surface area; CABG: coronary artery 
bypass graft; CHF: congestive heart failure; CRF: chronic renal failure; CVA: cerebrovascular accident; LV: left ventricle; MI: myocardial infarction; 
NSTE-ACS: non-ST-segment elevation acute coronary syndrome; PCI: percutaneous coronary intervention; PVD: peripheral vascular disease;  

























for females vs. 
males
Lesion characteristics
Number of diseased vessels, % 1 47.1 45.4 51.5
<0.00012 31.0 31.4 29.8
3 21.9 23.1 18.7
Coronary anatomic risk*, % High 24.3 25.4 21.2
<0.0001
Low 75.7 74.6 78.8
Procedural characteristics
Number of stented lesions (number 
of stented coronary segments), %
1 73.5 73.0 74.8
<0.0001
2 21.5 21.9 20.4
3 4.0 4.0 3.8
>3 0.6 0.6 0.7
Treated vessel, % Right coronary 34.8 34.6 35.4 0.005
Left anterior descending 41.4 40.0 45.2 <0.0001
Left circumflex 26.6 28.1 22.9 <0.0001
Left main 2.2 2.1 2.2 0.246
Arterial graft 0.4 0.5 0.3 <0.0001
Venous graft 2.9 3.3 1.9 <0.0001
Number of treated vessels, % 1 91.3 91.1 91.8
<0.0001
2 7.8 8.0 7.3
3 0.5 0.5 0.5
4 0.0 0.0 0.0
Bifurcation lesion, % 15.3 15.5 14.9 0.085
Intra-stent restenosis, % 7.2 7.5 6.5 <0.0001
Vascular access, % Femoral 81.2 80.6 82.7
<0.0001
Radial 15.3 15.9 13.8
Brachial, others 3.5 3.5 3.5
<0.0001
Closure device, % 26.1 26.4 25.5
* High anatomic risk: left main artery stenosis, 3-vessel disease, 2-vessel disease with proximal left anterior descending artery disease; low anatomic 
risk: other 2-vessel disease, 1-vessel disease.







































Figure 1. In-hospital complication rates after PCI for females vs. males and odds ratios for in-hospital complications for females vs. males. 
CABG: coronary artery bypass graft; CVA: cerebrovascular accident; MACCE: major adverse cardiac and cerebrovascular events; 
MI: myocardial infarction















1.8%, p=0.018), to STEMI (10.1% vs. 5.4%, p<0.0001). In each 
clinical subgroup, a significant gender-related difference was seen, 
with the worst prognosis in women (p<0.0001) (Figure 2). Women 
were more likely to have a MACCE (death, stroke or severe bleed-
ing) during hospital stay, with a rate of 3.1% in women and 2.0% 
in men (OR 1.55, 95% CI: 1.44-1.67, p<0.0001). The rate of severe 
bleeding was higher in female patients (Figure 1).
After univariate analysis of clinical, angiographic and procedural 
analyses, we identified independent risk factors for death in mul-
tivariate analysis (Table 4). In multivariate analysis, female gen-
der was a significant independent risk factor for in-hospital death 
(OR 1.35, 95% CI: 1.22-1.49, p<0.0001). The other independ-
ent risk factors were age, prior MI (OR 1.35, 95% CI: 1.12-1.56, 
p<0.0001), hypercholesterolaemia, prior PCI, prior PVD, prior 
VHD, CRF, high coronary anatomic risk, STEMI and cardiogenic 
shock. In multivariate analysis, female gender was an independent 
Table 3. Major in-hospital complications and outcomes: incidence 
and odds ratios for females vs. males.




Post-procedural MI, % 0.7 0.7 0.8 0.005
Bleeding during hospital stay, % 0.4 0.4 0.6 <0.0001
CVA, % 0.2 0.2 0.3 0.001
Renal failure requiring dialysis, % 0.5 0.4 0.6 0.001
Stent thrombosis, % 0.5 0.5 0.4 0.083
CABG, % 1.4 1.4 1.4 0.533
In-hospital death, % 1.8 1.6 2.5 <0.0001
STEMI, % 6.6 5.4 10.1 <0.0001
NSTE-ACS, % 2.0 1.8 2.4 0.018
Stabilised ACS, % 1.2 1.0 1.6 <0.0001
Elective PCI, others, % 0.5 0.5 0.7 0.003
MACCE (death, stroke, bleeding), % 2.3 2.0 3.1 <0.0001
STEMI, % 7.4 6.1 11.3 <0.0001
NSTE-ACS, % 2.5 2.3 3.1 0.004
Stabilised ACS, % 1.7 1.4 2.3 <0.0001
Elective PCI, others, % 0.9 0.8 1.1 0.001
Odds ratios for females  
vs. males
OR 95% CI p-value
Post-procedural MI 1.22 1.06 1.40 0.005
Bleeding during hospital stay 1.58 1.33 1.86 <0.0001
CVA 1.50 1.17 1.91 0.001
Renal failure requiring dialysis 1.32 1.11 1.56 0.001
Stent thrombosis 0.84 0.70 1.02 0.083
CABG 0.97 0.87 1.07 0.533
In-hospital death 1.57 1.44 1.70 <0.0001
MACCE (death, stroke, bleeding) 1.55 1.44 1.67 <0.0001
ACS: acute coronary syndrome; CABG: coronary artery bypass graft; CI: confidence interval; 
CVA: cerebrovascular accident; MACCE: major adverse cardiac and cerebrovascular events; 
MI: myocardial infarction; NSTE-ACS: non-ST-segment elevation acute coronary syndrome; 
STEMI: ST-segment elevation myocardial infarction
Table 4. Odds ratios for multivariable predictors of in-hospital 
events.
Variables OR 95% CI p-value
Death* (n=2,297)
Hypercholesterolaemia 0.590 0.534 0.653 <0.0001
Previous PCI 0.634 0.554 0.726 <0.0001
Age 1.047 1.043 1.052 <0.0001
Female gender 1.346 1.216 1.490 <0.0001
Previous CVA 1.346 1.088 1.664 0.006
Previous MI 1.348 1.172 1.551 <0.0001
Previous CHF 1.351 1.074 1.699 0.010
Previous PVD 1.465 1.253 1.712 <0.0001
High coronary anatomic risk 1.642 1.487 1.813 <0.0001
Valvulopathy 1.737 1.392 2.167 <0.0001
CRF 2.471 2.064 2.959 <0.0001
STEMI 4.322 3.895 4.796 <0.0001
Cardiogenic shock 29.492 26.362 32.994 <0.0001
CVA¶ (n=260)
Previous PCI 0.683 0.500 0.933 0.017
Age 1.020 1.009 1.032 <0.0001
Female gender 1.366 1.051 1.774 0.019
Previous CABG 1.600 1.106 2.314 0.013
CRF 1.771 1.100 2.851 0.019
STEMI 3.033 2.324 3.958 <0.0001
Previous CVA 4.193 2.893 6.076 <0.0001
Bleeding‡ (n=552)
Age 1.024 1.016 1.032 <0.0001
Female gender 1.365 1.141 1.632 0.001
Previous PVD 1.490 1.144 1.941 0.003
Previous CVA 1.524 1.069 2.170 0.020
CRF 2.244 1.650 3.052 <0.0001
STEMI 2.667 2.202 3.230 <0.0001
Cardiogenic shock 4.186 3.187 5.499 <0.0001
MACCE** (n=2,909)
Hypercholesterolaemia 0.648 0.595 0.706 <0.0001
Previous PCI 0.686 0.612 0.768 <0.0001
Age 1.040 1.036 1.044 <0.0001
Previous MI 1.253 1.110 1.413 <0.0001
Female gender 1.352 1.239 1.477 <0.0001
High-risk coronary anatomy 1.433 1.313 1.564 <0.0001
Previous CVA 1.529 1.279 1.828 <0.0001
Valvulopathy 1.568 1.287 1.910 <0.0001
Previous PVD 1.579 1.382 1.804 <0.0001
CRF 2.431 2.081 2.840 <0.0001
STEMI 3.578 3.267 3.918 <0.0001
Cardiogenic shock 23.829 21.452 26.468 <0.0001
*All variables included in the multivariate model were significant and reported in the table. 
¶History of peripheral vascular disease was also included in the multivariate model (p=NS). 
‡History of valvular heart disease and prior PCI were also included in the multivariate model 
(p=NS for both). **MACCE: death, CVA and bleeding. CABG: coronary artery bypass graft; 
CHF: congestive heart failure; CRF: chronic renal failure; CVA: cerebrovascular accident; 
MACCE: major adverse cardiac and cerebrovascular events; PCI: percutaneous coronary 














risk factor for bleeding (OR 1.37, 95% CI: 1.14-1.63, p=0.001), 
stroke (OR 1.37, 95% CI: 1.05-1.77, p=0.019) and MACCE (OR 
1.35, 95% CI: 1.24-1.48, p<0.0001) (Table 4).
Discussion
From the Belgian PCI registry, the main results of this study are 
marked gender-based differences in in-hospital mortality rates fol-
lowing PCI. Even after robust multivariable adjustment, female 
gender remained an independent predictor of mortality, bleeding, 
stroke and MACCE.
We observed significant differences between men and women 
in terms of clinical characteristics, angiographic characteristics, 
interventions and in-hospital outcomes. Baseline characteristics 
in our study showed that women were older at the time of PCI. It is 
known that women develop cardiovascular disease seven to ten 
years later than men, a difference thought to result, at least in part, 
from the protective role of endogenous oestrogen15. As hyperten-
sion and diabetes prevalence increases with age, the higher preva-
lence of hypertension and diabetes in our female cohort is partly 
in relation to the older age of female patients undergoing PCI. On 
the other hand, the higher prevalence of CAD in men16 is con-
sistent with the higher rate of prior MI and PCI observed in this 
subset of patients. In the literature, the rate of severe CAD and 
multivessel disease is lower in the female population compared 
to males17,18. This was confirmed in our study: the OR for a high-
risk coronary anatomy was 0.79 for women (95% CI: 0.77-0.81, 
p<0.0001) and coronary multivessel disease was less frequent 
in female patients. This apparent dissociation between a higher 





























All     Males     Females
Figure 2. In-hospital mortality rate according to gender and 
indication for PCI. ACS: acute coronary syndrome;  
NSTE-ACS: non-ST-segment elevation acute coronary syndrome; 
PCI: percutaneous coronary intervention; STEMI: ST-segment 
elevation myocardial infarction.
severity of ischaemic heart disease in women has been previously 
described19. However, the mechanism involved and the reasons 
explaining such discrepancy remain unclear. In cohort studies, 
gender bias could be responsible for decreased access to PCI for 
women with advanced CAD11. The mode of presentation of CAD, 
which varies according to gender, could also explain this observa-
tion: women more frequently have angina pectoris as first symp-
tom whereas men present more frequently with MI, influencing 
the access to coronary angiography20. This difference in the pro-
portions of acute and elective indications for PCI between male 
and female patients is confirmed in the present cohort.
There is controversy about mortality and adverse event rates 
between men and women undergoing PCI. Early studies analys-
ing gender differences in clinical outcomes showed that interven-
tions in women were associated with higher rates of complications 
and higher rates of intervention failure21. It has been argued that 
these results were secondary to unadjusted analyses, clinical char-
acteristics and comorbidities being responsible for the observed 
differences. Currently, it remains clear that in unadjusted analysis 
women have poorer outcomes than men following PCI. To identify 
the role of gender on outcomes, several studies with adjusted analy-
ses for clinical characteristics (i.e., robust multivariate analysis or 
propensity score analysis) have been reported recently with varying 
results. Some studies show a persistent gender-related difference 
in outcomes after adjustment12,22, while others show that sex is not 
an independent factor of outcomes13,23. The most recent large stud-
ies performed in the DES era do not show gender-specific differ-
ences in mortality following PCI after adjustments14,24. Conversely, 
female gender was an independent correlate of long-term mortal-
ity in the PCI arm of the SYNTAX trial, despite adjustments for 
risk factors25,26. In our study, there is a significant difference in in-
hospital mortality between men and women after PCI. Even after 
multivariate analysis and multiple adjustment for confounding fac-
tors, female gender remains an independent predictor of in-hospital 
death and MACCE.
Mortality rate after PCI varies according to PCI indication, as 
observed in the European registry Euro Heart Survey of PCI27. 
Significant sex-related difference in mortality is observed in each 
clinical subgroup, particularly in patients presenting with STEMI. 
A worse prognosis in women admitted for acute coronary syndrome 
(ACS) contributes to the difference in mortality rates between 
women and men.
The difference in mortality rate between genders can be explained 
partly by older age and more frequent comorbidities in the female 
cohort. Nevertheless, in our study, female gender is an independ-
ent predictor of death after multivariate analysis with an increase in 
risk of death of 35%. Complications, such as severe bleeding, acute 
renal failure or stroke are more frequent in female patients, particu-
larly in patients presenting with ACS. These complications may be 
considered as a factor contributing to the increased mortality rate in 
females undergoing PCI.
The influence of female gender on outcomes might be 
explained by differences in coronary physiology, anatomy and in 















cardiovascular risk factors. As some of these factors may be under-
evaluated or unknown, female gender may appear as an independ-
ent predictor of adverse outcome even though it may be associated 
with other causative factors (hormonal status, endothelial dysfunc-
tion, micro-circulation disorders, etc.)5.
There is a lack of consistency across studies concerning the influ-
ence of gender on clinical outcome after PCI. Many earlier stud-
ies relied on relatively small samples, were single-centre studies, 
focused on different populations or did not analyse the same fac-
tors. Additionally, thanks to better PCI techniques and medical 
management, adverse event rates have decreased in high-risk popu-
lations, including women. Nowadays, it is statistically more dif-
ficult to show significant event rate difference among groups, and 
large population analyses are needed28.
Limitations
Our study has some limitations. First, as a multicentre registry, it 
offers observational data on selected patients undergoing PCI. Thus, 
it is limited to patients who have had PCI and does not account for 
the outcomes of women who undergo cardiac catheterisation with-
out intervention and women who are referred for CABG. Second, 
even though multivariate analysis was performed, we cannot 
exclude the influence of confounding factors in our results. Finally, 
SYNTAX scores were not registered and are lacking in the analysis. 
SYNTAX scores would probably be more sensitive to determine 
the influence of lesion severity on the outcomes.
Conclusions
In conclusion, the results of this study demonstrate a significant 
difference in in-hospital mortality rates between men and women 
undergoing PCI. This difference is particularly marked in patients 
undergoing PCI for ACS. After robust adjustment for known pre-
dictors of mortality, female gender remained an independent predic-
tor of death, being associated with a 35% increase in risk of death 
as compared to male gender. However, there is a lack of consist-
ency in findings across studies evaluating gender difference in out-
comes after PCI. Larger studies in populations treated with current 
PCI techniques and cardiovascular medical treatment are needed to 
identify factors explaining these differences in outcomes.
Impact on daily practice
Female gender is associated with worse outcomes in case of 
ischaemic heart disease and after PCI, particularly in patients 
undergoing PCI for ACS. After adjustment for clinical and ana-
tomical variables, results vary between studies and the influ-
ence of gender as an independent risk factor for outcomes after 
PCI is still under debate. In daily practice, gender differences in 
terms of presentation of CAD and outcomes after PCI have to be 
considered.
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